ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $505K of Zentalis Pharmaceuticals, Inc.
Sold$504,769
$50.48Price
10,000Shares
−3%Stake
What ZNTL did after the filing
- The stock from Tue, Apr 5 close, $49.24
- −51.1%
- S&P 500, same days
- −13.1%
Measured over 30 trading days, to the May 18 close.
Traded Tue, Apr 5. Filed Tue, Apr 5, 2:52 PM ET, during the session. Returns use the Apr 5 close and the May 18 close. Not investment advice.